Crespo Blas Coll
CIK: 0002037144
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Structure Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Sep 21, 2026GPCR
Structure Therapeutics Inc.
Sale(S)DirectAmerican Depositary Shares
4K shares at avg. $36.15- - Sep 21, 2026GPCR
Structure Therapeutics Inc.
Conversion(C)Direct12K shares- - Sep 18, 2026GPCR
Structure Therapeutics Inc.
Tax Payment(F)Direct10.6K shares at avg. $11.67$124K - Mar 19, 2026GPCR
Structure Therapeutics Inc.
Award(A)Direct75.9K shares- - Mar 3, 2026GPCR
Structure Therapeutics Inc.
Tax Payment(F)Direct11.8K shares at avg. $20.99$248K - Sep 18, 2025GPCR
Structure Therapeutics Inc.
Tax Payment(F)Direct8.1K shares at avg. $7.74$63K - Jul 1, 2025GPCR
Structure Therapeutics Inc.
Award(A)Direct8K shares- - Jul 1, 2025GPCR
Structure Therapeutics Inc.
Tax Payment(F)Direct1.4K shares at avg. $6.84$10K - May 21, 2025GPCR
Structure Therapeutics Inc.
Award(A)DirectAmerican Depositary Shares
429 shares- - Mar 15, 2025GPCR
Structure Therapeutics Inc.
Award(A)Direct117K shares- - Mar 1, 2025GPCR
Structure Therapeutics Inc.
Tax Payment(F)Direct1.2K shares at avg. $7.92$10K - Nov 20, 2024GPCR
Structure Therapeutics Inc.
Award(A)DirectAmerican Depositary Shares
363 shares- - Sep 18, 2024GPCR
Structure Therapeutics Inc.
Award(A)Direct90.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 21, 2026 | GPCR Structure Therapeutics Inc. | Sale(S) American Depositary Shares | 4,008 | $36.15 | - | Direct |
| Sep 21, 2026 | GPCR Structure Therapeutics Inc. | Conversion(C) | 12,024 | - | $0 | Direct |
| Sep 18, 2026 | GPCR Structure Therapeutics Inc. | Tax Payment(F) | 10,626 | $11.67 | $124,005 | Direct |
| Mar 19, 2026 | GPCR Structure Therapeutics Inc. | Award(A) | 75,897 | - | $0 | Direct |
| Mar 3, 2026 | GPCR Structure Therapeutics Inc. | Tax Payment(F) | 11,826 | $20.99 | $248,228 | Direct |
| Sep 18, 2025 | GPCR Structure Therapeutics Inc. | Tax Payment(F) | 8,106 | $7.74 | $62,767 | Direct |
| Jul 1, 2025 | GPCR Structure Therapeutics Inc. | Award(A) | 7,992 | - | - | Direct |
| Jul 1, 2025 | GPCR Structure Therapeutics Inc. | Tax Payment(F) | 1,434 | $6.84 | $9,804 | Direct |
| May 21, 2025 | GPCR Structure Therapeutics Inc. | Award(A) American Depositary Shares | 429 | - | - | Direct |
| Mar 15, 2025 | GPCR Structure Therapeutics Inc. | Award(A) | 116,988 | - | - | Direct |
| Mar 1, 2025 | GPCR Structure Therapeutics Inc. | Tax Payment(F) | 1,233 | $7.92 | $9,761 | Direct |
| Nov 20, 2024 | GPCR Structure Therapeutics Inc. | Award(A) American Depositary Shares | 363 | - | - | Direct |
| Sep 18, 2024 | GPCR Structure Therapeutics Inc. | Award(A) | 90,600 | - | $0 | Direct |
1-13 of 13 transactions
About Coll Crespo Blas
Coll Crespo Blas (SEC CIK 0002037144) files insider reports with the SEC as CHIEF MEDICAL OFFICER of Structure Therapeutics Inc. (GPCR).
Signal8 holds 8 ownership filings by Coll Crespo Blas (1 Form 3, 7 Form 4), filed between Sep 20, 2024 and Sep 22, 2026. Those filings report 13 transactions, from Sep 18, 2024 to Sep 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Coll Crespo Blas's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Coll Crespo Blas
- Sep 21, 2026: Open-market sale of GPCR derivative securities (Form 4, code S).
- Sep 21, 2026: Conversion of GPCR shares (Form 4, code C).
- Sep 18, 2026: Tax withholding of GPCR shares (Form 4, code F).
- Mar 19, 2026: Grant or award of GPCR shares (Form 4, code A).
- Mar 3, 2026: Tax withholding of GPCR shares (Form 4, code F).
Other insiders filing for Structure Therapeutics Inc. (GPCR)
- Lin Xichen, CHIEF SCIENTIFIC OFFICER
- Berrios John Joseph, Chief Commercial Officer
- FMR LLC, 10% Owner
- Russell Angus C., Director
- LOVE TED W, Director
- Waldstreicher Joanne, Director